Silence Therapeutics plc Increase Decrease In Cash And Cash Equivalents
Silence Therapeutics plc (SLN) reported Increase Decrease In Cash And Cash Equivalents of GBP 14.27 million for the 12-month period ending 2020-12-31, per its 20-F/A filed 2021-04-29.
Discontinued › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2021-04-29
| Period end | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|
| 2020-12-31 | 14.27M GBP 20-F/A · filed 2021-04-29 |
| 2019-12-31 | -8.02M GBP 20-F/A · filed 2021-04-29 |
| 2018-12-31 | -21.25M GBP 20-F/A · filed 2021-04-29 |